Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ INC

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 31
  • 0 comments

FDA approve FLUVASTATIN SODIUM

Comment Full text

BARR

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 33
  • 0 comments

FDA approve ETHINYL ESTRADIOL; NORGESTIMATE

Comment Full text

MYLAN

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 31
  • 0 comments

FDA approve ETHINYL ESTRADIOL; NORGESTIMATE

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 30
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 29
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

APOTEX

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 30
  • 0 comments

FDA approve CARFILZOMIB

Comment Full text

HIKMA FARMACEUTICA

  • FDA Approval
  • Nov. 28, 2023, 09:45 UTC
  • 34
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 28, 2023, 09:45 UTC
  • 31
  • 0 comments

FDA approve MESALAMINE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 28, 2023, 09:45 UTC
  • 34
  • 0 comments

FDA approve MESALAMINE

Comment Full text

APOTEX

  • FDA Approval
  • Nov. 28, 2023, 09:45 UTC
  • 38
  • 0 comments

FDA approve FLUVOXAMINE MALEATE

Comment Full text
  • Previous
  • 628
  • 629
  • 630
  • 631
  • 632
  • Next

Search

News categories

  • Technical Exchange News(11955)
  • Event(4938)
  • SEC News(246239)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148387)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin